Indivisible Partners’s Royalty Pharma RPRX Stock Holding History

Indivisible Partners’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$212K	Buy	+3,635	New	+$214K	0.01%	694

Other funds holding RPRX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Fideuram Asset Management (Ireland) Dublin 1 $4.57B AUM 30.36% 1-Year Est. Return

Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Indivisible Partners's RPRX Position: Q3 2026 in Review

Indivisible Partners opened a new position in Royalty Pharma (RPRX) in Q3 2026: 3,635 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #694 among its holdings.

208 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

Indivisible Partners held 3,635 shares of Royalty Pharma worth $212K as of Q3 2026.
Royalty Pharma was a new Indivisible Partners position in Q3 2026.
Royalty Pharma made up 0.01% of Indivisible Partners's portfolio in Q3 2026, its #694 holding.
208 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.